Gocovri for Parkinson's Disease User Reviews

Rating: 8.0

Gocovri has an average rating of 8.0 out of 10 from a total of 3 reviews for the treatment of parkinson's disease. 100% of reviewers reported a positive experience, while 0% reported a negative experience.

10		0%
9		0%
8		100%
7		0%
6		0%
5		0%
4		0%
3		0%
2		0%
1		0%

Bob...
Taken for 1 to 6 months
December 31, 2022

"Gocovri seemed to be better at controlling dyskinesia than Amantadine. There was less abdominal cramping in the morning. I was taking the 68.5 mg capsule, which is the lowest dose before bedtime. However, Gocovri is very expensive. My co-pay was close to $450 per month. I felt the difference in comparing the two medications' ability to control the dyskinesia was not sufficient enough to warrant the excessive cost of Gocovri."

8 / 10

Was this helpful?Yes No

7 Report

Suz...
Taken for 1 to 6 months
December 7, 2023

"Gocovri has reduced the length of time of my dyskinesia and reduced the severity as well. I am forced to go off of it due to the cost. Seems like the cost could be reduced to have more users. I can't afford $900 per month and then the donut hole! Back to Amantadine IR."

8 / 10

Was this helpful?Yes No

4 Report

Ano...
Taken for 1 to 6 months
September 9, 2025

"Well, it does seem to do what it’s supposed to do. It has given me, after six weeks of use, such vivid dreams and nightmares that it takes me a long time to fall back to sleep, so I think I’m either going to cut down to a 1/2 dose or switch back to the daytime version. I need to talk to my doctor."

8 / 10

Was this helpful?Yes No

0 Report